CD3D2 1.5 Capsule
Marketer
Jagsam Pharma
Salt Composition
Cariprazine (1.5mg)
Overview CD3D2 1.5 Capsule
This medication, CD3D2 1.5 Capsule, treats schizophrenia (a mental illness causing hallucinations, delusions, and impaired thinking/behavior) and mania, including those associated with bipolar disorder. It can be taken with or without food, but consistent daily timing ensures stable blood levels. Follow your doctor's prescribed dosage and duration; if a dose is missed, take it immediately upon recall. Abrupt cessation is dangerous and may worsen symptoms; consult your physician before stopping. Immediately discontinue use if neuroleptic malignant syndrome (NMS) occurs (fever, muscle stiffness, altered consciousness, or seizures). Common side effects include extrapyramidal symptoms, akathisia, indigestion, vomiting, drowsiness, and restlessness. Initial postural hypotension (sudden blood pressure drop upon standing) may occur; rise slowly from a seated or lying position. Dizziness and sleepiness are also possible; avoid driving or mentally demanding tasks until effects are known. Weight gain is a potential side effect, mitigated by healthy eating and exercise. Increased diabetes risk exists; regular glucose monitoring is advised. Report any unusual mood or behavior changes, new or worsening depression, or suicidal thoughts to your doctor promptly.
Primary Ingredients of CD3D2 1.5 Capsule
No text was provided to rewrite.
Uses of CD3D2 1.5 Capsule
Psychotic disorders involving psychosis and mood disturbances
Major Benefits of CD3D2 1.5 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for CD3D2 1.5 Capsule. This medication can be administered with or without food, although consistent timing is recommended.
Common Side effects of CD3D2 1.5 Capsule:
- Extrapyramidal symptoms
- Akathisia (inability to stay still)
- Dyspepsia
- Sleepiness
- Restlessness
How to use CD3D2 1.5 Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for CD3D2 1.5 Capsule. This medication can be administered with or without food, however, consistent timing is recommended.
How CD3D2 1.5 Capsule works:
CD3D2 1.5 Capsule helps manage bipolar disorder and schizophrenia by restoring equilibrium to brain neurotransmitters like dopamine and serotonin, leading to improved mood, cognitive function, and behavior.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside CD3D2 1.5 Capsule lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of CD3D2 1.5 Capsule during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might consider prescribing it if the potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of CD3D2 1.5 Capsule while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The impact of CD3D2 1.5 Capsule on driving ability is undetermined. Refrain from driving if you experience any symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
CD3D2 1.5 Capsule poses no safety concerns for individuals with renal impairment; therefore, no dosage modification is necessary.
LiverSAFE IF PRESCRIBED
CD3D2 1.5 Capsule poses no safety concerns for patients with hepatic impairment; dosage modification is unnecessary.
What if you forget to take CD3D2 1.5 Capsule :
Should you forget to take a CD3D2 1.5 Capsule, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About CD3D2 1.5 Capsule
| Label | Value |
|---|---|
| Chemical Classification | Six-membered nitrogen-containing rings |
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) Neurology |
| Active Class | Nontypical Antipsychotics |



